Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer

Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer

Single Donor Human Whole Blood from Innovative Research was used in the following study:

 

Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer

JUNGWHOI LEE, JUNGSUL LEE and JAE HOON KIM

Anticancer Research
11/1/2019

“…The aim of this study was to investigate matrix metalloproteinase 11 (MMP11) as a promising biomarker in human pancreatic cancer. …Whole blood samples collection. A total of 12 different whole blood samples from pancreatic cancer patients and 16 different samples from healthy donors were purchased from Innovative (21) (Novi, MI, USA)…”

 

Related products available from Innovative Research also include: